Francesco Giotta Selected Research

Francesco Giotta Research Topics

Disease

47	Breast Neoplasms (Breast Cancer) 03/2024 - 06/2002
26	Neoplasms (Cancer) 01/2023 - 05/2006
7	Neoplasm Metastasis (Metastasis) 07/2022 - 07/2006
5	Triple Negative Breast Neoplasms 01/2023 - 09/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2005 - 10/2002
2	Diarrhea 03/2023 - 02/2013
2	Thrombosis (Thrombus) 08/2022 - 01/2022
2	Obesity 11/2020 - 08/2019
2	Hypertension (High Blood Pressure) 08/2019 - 01/2012
2	Brain Neoplasms (Brain Tumor) 01/2019 - 05/2006
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 03/2023
1	Seminoma 08/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2022
1	Inflammation (Inflammations) 07/2022
1	Tachycardia (Tachyarrhythmias) 04/2022
1	Ventricular Tachycardia 04/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2021
1	COVID-19 05/2021
1	Nausea 01/2020
1	Motion Sickness (Airsickness) 01/2020
1	Vomiting 01/2020
1	Endometrial Neoplasms (Endometrial Cancer) 10/2019
1	Thyroid Neoplasms (Thyroid Cancer) 08/2019
1	Atrial Fibrillation 08/2019
1	Papillary Thyroid Cancer 08/2019
1	Bone Diseases (Bone Disease) 01/2018
1	Disease Progression 01/2018
1	Male Breast Neoplasms (Male Breast Cancer) 11/2016

Drug/Important Bio-Agent (IBA)

10	Trastuzumab (Herceptin)FDA Link 11/2023 - 01/2012
6	Hormones (Hormone)IBA 03/2023 - 09/2012
6	human ERBB2 proteinIBA 01/2021 - 01/2012
6	pertuzumabIBA 01/2021 - 01/2017
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 06/2012
5	Vinorelbine (Navelbine)FDA LinkGeneric 01/2018 - 06/2002
5	Docetaxel (Taxotere)FDA Link 04/2014 - 10/2002
5	Epirubicin (Ellence)FDA LinkGeneric 11/2013 - 06/2002
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2012
4	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 11/2005
4	AnthracyclinesIBA 04/2011 - 06/2002
3	ErbB Receptors (EGF Receptor)IBA 11/2023 - 03/2023
3	Capecitabine (Xeloda)FDA Link 01/2023 - 11/2013
3	Epidermal Growth Factor (EGF)IBA 01/2021 - 02/2013
3	Ado-Trastuzumab EmtansineIBA 01/2021 - 01/2017
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 02/2013
3	sodium-hydrogen exchanger regulatory factorIBA 02/2020 - 09/2017
3	Estrogens (Estrogen)FDA Link 10/2014 - 06/2012
3	Gemcitabine FDA Link 04/2014 - 10/2002
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 08/2022 - 01/2022
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2020
2	Estrogen ReceptorsIBA 01/2021 - 09/2012
2	eribulin FDA Link 01/2021 - 11/2016
2	taxaneIBA 10/2019 - 01/2019
2	Phenobarbital (Luminal)FDA Link 04/2016 - 06/2012
2	Peptides (Polypeptides)IBA 11/2013 - 02/2013
2	GhrelinIBA 11/2013 - 02/2013
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2011 - 06/2002
1	abemaciclibIBA 03/2023
1	Cyclin-Dependent Kinase 4IBA 03/2023
1	palbociclibIBA 10/2022
1	edoxabanIBA 08/2022
1	Enoxaparin (Lovenox)FDA LinkGeneric 08/2022
1	AnticoagulantsIBA 08/2022
1	Adenosine Triphosphate (ATP)IBA 07/2022
1	Adenosine (Adenocard)FDA LinkGeneric 07/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Tinzaparin (Innohep)FDA Link 01/2022
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2021
1	CytokinesIBA 01/2021
1	InflammasomesIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 11/2020
1	Palonosetron (Aloxi)FDA Link 01/2020
1	netupitantIBA 01/2020
1	Biological FactorsIBA 11/2019
1	Androgen Receptors (Androgen Receptor)IBA 09/2019
1	IodineIBA 08/2019
1	lenvatinibIBA 08/2019
1	CateninsIBA 07/2019
1	Taxoids (Taxanes)IBA 01/2019
1	130-nm albumin-bound paclitaxelIBA 01/2018
1	Diphosphonates (Bisphosphonates)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 09/2017
1	exemestane (Aromasin)FDA Link 06/2017
1	Everolimus FDA Link 06/2017
1	Poly (ADP-Ribose) Polymerase-1IBA 05/2016
1	Adenosine Diphosphate (ADP)IBA 05/2016
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2016
1	BRCA1 ProteinIBA 05/2016
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 05/2016
1	MotilinIBA 11/2013
1	LeptinIBA 11/2013
1	Lapatinib (GW572016)FDA Link 11/2013
1	GastrinsIBA 11/2013

Therapy/Procedure

20	Therapeutics 11/2023 - 01/2012
19	Drug Therapy (Chemotherapy) 11/2023 - 06/2002
5	Neoadjuvant Therapy 03/2024 - 04/2021
4	Adjuvant Chemotherapy 10/2014 - 06/2012
2	Immunotherapy 01/2022 - 02/2020
1	Polypharmacy 03/2023
1	Catheter Ablation 04/2022